Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

MRX vs PDX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MRX Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)

MRX Overall Winner 6-Pillar Tally: MRX 5 – 1 PDX Matrix Metrics: MRX 9 – 1 PDX

As of Nov 16, 2026, Marex Group plc (MRX) is the stronger overall head-to-head candidate over PIMCO Dynamic Income Strategy Fund (PDX) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MRX carries a Unified Composite Score of 49.5/100 (HOLD) at $70.60 (9.8x Forward P/E, 15.9% operating margin), whereas PDX carries 45.3/100 (HOLD) at $20.06 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: MRX trades in a Neutral technical trend (BREAKOUT options phase, RSI 52.3); meanwhile PDX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MRX vs PDX
MRX NASDAQ Head-to-Head Winner
Marex Group plc Ordinary Shares
Security & Commodity Brokers, Dealers, Exchanges & Services
$70.60
-0.17% 1D
Market Cap $5.1B
TTM Revenue $3.78B
Forward P/E 9.8x
Beta / 30D Vol 0.85β · 53% Vol
Unified Composite Score
49.5 / 100 HOLD
Tech 25.0 Fund 43.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 52.3 · SMA20: $68.77 · SMA50: $70.91
PDX NYSE
PIMCO Dynamic Income Strategy Fund
Institutional Equity
$20.06
-0.5% 1D
Market Cap $1.1B
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.19β · 16% Vol
Unified Composite Score
45.3 / 100 HOLD
Tech 41.0 Fund 48.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.4%) with fading momentum, RSI 41
RSI-14: 40.7 · SMA20: $20.47 · SMA50: $20.59

6-Pillar Scorecard Institutional Category Breakdown (MRX 5 – 1 PDX)

Columns: Metric · MRX · PDX
1. Valuation Multiples MRX
Forward P/E 9.8x N/M
Trailing P/E 12.8x N/M
PEG Ratio N/M N/M
EV / Revenue 4.0x N/M
2. Growth & Scale MRX
Revenue Growth (YoY) +43.1% N/A
Earnings Growth (YoY) +62.6% N/A
TTM Revenue (USD) $3.78B N/A
Market Cap $5.1B $1.1B
3. Profitability & Quality MRX
Gross Margin 71.5% N/A
Operating Margin 15.9% N/A
Net Profit Margin 12.8% N/A
Return on Equity (ROE) 28.4% N/A
4. Balance Sheet & Cash Flow PDX
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $10.0B Net Debt (6.72x D/E) N/A ROE
Dividend Yield 0.86% None (0.00%)
5. Options & Positioning MRX
Options Structure Phase BREAKOUT UNCLASSIFIED
Current IV / %ile 46.0% (7th %ile) N/A (N/A)
Put/Call OI Skew 0.04x (Call-Skewed) N/A
OBV Trend / Tech Phase ACCUMULATION · Neutral NEUTRAL · Distribution
6. R&D & Supply-Chain Moat MRX
OpEx & R&D Intensity 55.6% of Rev ($2.10B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Capital Markets Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MRX (9) vs PDX (1)
Institutional Metric MRX PDX Criterion Row Edge
Market Capitalization
Scale
$5.1B $1.1B Larger Scale MRX
Trailing P/E Ratio
Valuation
12.8x N/M Lower Multiple MRX
Forward P/E Ratio
Valuation
9.8x N/M Lower Multiple MRX
Revenue Growth (YoY)
Growth
+43.1% N/A Higher Growth MRX
Operating Margin (TTM)
Profitability
15.9% N/A Higher Margin MRX
Net Profit Margin
Profitability
12.8% N/A Higher Margin MRX
Return on Equity (ROE)
Capital Efficiency
28.4% N/A Higher ROE MRX
52-Week Range Position
Momentum
82% ($31–$79) 42% ($18–$22) Stronger Trend MRX
Beta / 30D Volatility
Risk Regime
0.85β · 53% Vol 0.19β · 16% Vol Lower Realized Risk PDX
Unified Institutional Score
Composite Signal
49.5 / 100 (HOLD) 45.3 / 100 (HOLD) Higher Composite MRX
Trailing 12M Revenue (USD)
Operating Scale
$3.78B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
71.5% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 4.0x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($10.0B Net Debt (6.72x D/E)) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PDX +0.06 pp
MRX: +0.14% · PDX: +0.2%
3M Horizon MRX +5.91 pp
MRX: -1.78% · PDX: -7.69%
6M Horizon MRX +32.55 pp
MRX: +25.42% · PDX: -7.13%
1Y Horizon MRX +111.24 pp
MRX: +103.55% · PDX: -7.69%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MRX vs PDX. Trailing 12-month operating profitability (MRX 15.9% vs PDX N/A) and valuation multiples (MRX 9.8x vs PDX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

MRX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.78B
Gross Margin71.5%
Op. Margin15.9%
ROE / Fwd P/E28.4% · 9.8x
PDX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MRX BREAKOUT
109d in phase · OBV ACCUMULATION
Current IV 46.0%
IV Percentile 7th %ile
Put/Call OI Skew 0.04x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact MRX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PDX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PDX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MRX Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $5.1B market capitalization and 15.9% operating margin.
OpEx & R&D Reinvestment 55.6% of Rev ($2.10B)
90D Engineering Disclosures 0 Published
PDX Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $1.1B market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ MRX vs PDX Key Questions & Quantitative Answers

As of Nov 16, 2026, Marex Group plc (MRX) is the stronger overall head-to-head candidate over PIMCO Dynamic Income Strategy Fund (PDX) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MRX carries a Unified Composite Score of 49.5/100 (HOLD) at $70.60 (9.8x Forward P/E, 15.9% operating margin), whereas PDX carries 45.3/100 (HOLD) at $20.06 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: MRX trades in a Neutral technical trend (BREAKOUT options phase, RSI 52.3); meanwhile PDX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MRX leads the Growth & Scale pillar: MRX posts +43.1% YoY revenue growth and +62.6% YoY earnings growth on $3.78B TTM revenue (71.5% gross margin, 15.9% operating margin), compared with PDX at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, MRX generates $3.78B in USD-normalized revenue versus N/A for PDX. In operating R&D and SG&A reinvestment, MRX deploys 55.6% of Rev ($2.10B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PDX.

MRX screens cheaper on headline valuation multiples. MRX trades at 9.8x Forward P/E, 12.8x Trailing P/E, N/M PEG, and 4.0x EV/Revenue (unreported cash flow margin), whereas PDX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MRX (28.4% ROE) versus PDX (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, MRX carries 46.0% implied volatility (7th %ile, Compressed (<25th %ile)), a 0.04x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (0.85β · 53% Vol realized risk). By comparison, PDX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.19β · 16% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.